🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12219+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12219 recruiting trials

Phase 1, PHASE2RecruitingNCT06481306

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 19 sites📅 Started Jul 2024View details ↗
Phase 2, PHASE3RecruitingNCT06413654

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

🏥 Shanghai Jiaolian Drug Research and Development Co., Ltd📍 51 sites📅 Started Jul 2024View details ↗
RecruitingNCT06984445

Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia

👨‍⚕️ Agnieszka A. Drozdowska-Szymczak, MD, PhD, Institute of Mother and Child in Warsaw, Poland📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06287268

Revolade Tablets Specified Drug-use Survey

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 17 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06207799

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

👨‍⚕️ Qaiser Bashir, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT06456580

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

🏥 Vor Biopharma📍 84 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT05649956

Letrozole in Uterine Leiomyosarcoma

👨‍⚕️ Bradley Corr, MD, University of Colorado, Denver📍 25 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT05952024

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

🏥 AstraZeneca📍 48 sites📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT06456346

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 166 sites📅 Started Jul 2024View details ↗
Phase 3RecruitingNCT06427395

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

👨‍⚕️ Deven Parmar, Zydus Therapeutics Inc.📍 28 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06128070

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

👨‍⚕️ Haris Ali, City of Hope Medical Center📍 1 site📅 Started Jul 2024View details ↗
Phase 1RecruitingNCT06504290

Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

👨‍⚕️ Gang Wang, Beijing Anding Hospital of Capital Medical University📍 4 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06498752

MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer

🏥 Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06477965

Embo Registry; National Registry for Artery Embolization

👨‍⚕️ Siddhartha Rao, MD, Vascular Solutions of North Carolina📍 2 sites📅 Started Jul 2024View details ↗
NARecruitingNCT06622915

Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome

🏥 Sohag University📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06096779

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 61 sites📅 Started Jul 2024View details ↗
NARecruitingNCT06477263

NeuroCytotron in the Treatment of Autism Spectrum Disorder

👨‍⚕️ J R Trujillo, jrtrujillo@neurocytonix.com📍 1 site📅 Started Jul 2024View details ↗
EARLY_Phase 1RecruitingNCT06511349

Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

🏥 RenJi Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06029270

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

👨‍⚕️ Brigette B Ma, NRG Oncology📍 77 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06440850

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

👨‍⚕️ Sasan Fazeli, City of Hope Medical Center📍 1 site📅 Started Jul 2024View details ↗
← PreviousPage 268 of 611Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →